Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature

Differentiation syndrome (DS) is a potentially fatal adverse drug reaction caused by the so-called differentiating agents such as all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), used for remission induction in the treatment of the M3 subtype of acute myeloid leukemia (AML), acute promyelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparovic, Lucia, Weiler, Stefan, Higi, Lukas, Burden, Andrea M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603213/
https://www.ncbi.nlm.nih.gov/pubmed/33081000
http://dx.doi.org/10.3390/jcm9103342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603213/
https://www.ncbi.nlm.nih.gov/pubmed/33081000
http://dx.doi.org/10.3390/jcm9103342

Ejemplares similares